(Q39458523)

12 September 2017

title

Methadone in cancer pain. (English)

1 reference

12 September 2017

Mercadante S

1

1 reference

12 September 2017

publication date

1 January 1997

1 reference

12 September 2017

published in

European Journal of Pain

1 reference

12 September 2017

volume

1

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

77-83; discussion 84-5

1 reference

Comment on Bruera et al., Local toxicity with subcutaneous methadone. Experience of two centers

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Clinical efficacy of methadone in patients refractory to other mu-opioid receptor agonist analgesics for management of terminal cancer pain. Case presentations and discussion of incomplete cross-tolerance among opioid agonist analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Methadone in the management of cancer pain: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Individual variability in the response to different opioids: report of five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Blind comparison of once-daily and twice-daily dosage schedules in a methadone program

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Does intravenous methadone provide longer lasting analgesia than intravenous morphine? A randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Differences in efficacies between morphine and methadone demonstrated in the guinea pig ileum: a possible explanation for previous observations on incomplete opioid cross-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Intrathecal methadone: a dose-response study and comparison with intrathecal morphine 0.5 mg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Stereoselective pharmacokinetics of methadone in chronic pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Opioid hyperexcitability: the application of alternate opioid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Patient-controlled analgesia with oral methadone in cancer pain: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Morphine- and methadone-tolerant mice differ in cross-tolerance to other opiates. Heterogeneity in opioid mechanisms indicated

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Estimation of methadone clearance: application in the management of cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Opiate reduction in chronic pain patients: a comparison of patient-controlled reduction and staff controlled cocktail methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Rectal methadone in cancer patients with pain. A preliminary clinical and pharmacokinetic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Methadone and the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

A randomized study on oral administration of morphine and methadone in the treatment of cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Methadone in man: Pharmacokinetic and excretion studies in acute and chronic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Individualized use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Sublingual absorption of selected opioid analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Use of methadone in a highly tolerant patient receiving parenteral hydromorphone

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Local toxicity with subcutaneous methadone. Experience of two centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Custom-made suppositories of methadone for severe cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Does intravenous methadone provide longer lasting analgesia than intravenous morphine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Plasma levels and symptom complaints in patients maintained on daily dosage of methadone hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Respiratory depression in a patient receiving oral methadone for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Intrathecal methadone and morphine for postoperative analgesia: a comparison of the efficacy, duration, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Methadone use in patients with chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Effects of liver disease on fecal excretion of methadone and its unconjugated metabolites in maintenance patients. Quantitation by direct probe chemical ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Successful use of methadone in nociceptive cancer pain unresponsive to morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Methadone in pain uncontrolled by morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Effect of urinary pH on the disposition of methadone in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Pharmacokinetics of methadone during maintenance treatment: adaptive changes during the induction phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

Cancer pain control with a combination of methadone, amitriptyline, and non-narcotic analgesic therapy: a case series analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2897%2990064-1

10.1016/S1090-3801(97)90064-1

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference